ArticleTechnology in cancer research & treatment
Equivalent-Uniform-Dose Optimization for Spatially Fractionated Radiation Therapy.
Article in Technology in cancer research & treatment. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Bibliometric analysis of global research trends in spatially fractionated radiotherapy.Frontiers in oncology · 2026Pooled it
- The future is not always uniform: rethinking radiotherapy through spatial fractionation.Nature reviews. Clinical oncology · 2026Review
- Exploratory personalized radiobiological modeling of bystander and immune effects to inform SFRT-SBRT scheduling.Medical physics · 2026Article
- Photon minibeam-based LATTICE radiotherapy for small and medium-sized tumors: A dosimetric planning study.Medical physics · 2026Article
- Spatially fractionated radiation therapy (SFRT): a scoping review of dosimetric and biological evidence supporting a valley dose-driven translational framework.Radiation oncology (London, England) · 2026Article
- Exosome-loaded nanoradiosensitizers in radiotherapy for preventing post-irradiation tumor recurrence: mechanisms, preclinical evidence, and translational challenges.Discover nano · 2026Review
- Dose optimization with fully flexible vertex positioning for LATTICE radiotherapy.Medical physics · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
BackgroundSpatially fractionated radiotherapy (SFRT) intentionally creates spatially-modulated peak-valley dose patterns for improving the tumor control or/and the sparing of organs at risk, compared to conventional radiotherapy (CONV). Evaluating non-uniform dose distributions using conventional physical dose does not fully account for the biological effectiveness of SFRT. In this study, we adopt the equivalent uniform dose (EUD) as a surrogate metric to evaluate non-uniform dose distributions.PurposeThis work will develop a SFRT treatment planning method with EUD optimization, which is the first-of-its-kind to the best of our knowledge.MethodsThe SFRT scenario of proton GRID with uniform target dose is considered in this work for dose-only optimization (DO) and joint dose and peak-valley-dose-ratio (PVDR) optimization (JDPO) respectively. In addition to dose and PVDR optimization, SFRT treatment planning also optimizes the EUD. The EUD used in this work is based on cell survival as modeled by the linear-quadratic model. The EUD optimization problem is solved by: (1) iterative convex relaxation to decouple the nonconvex dose-volume-histogram constraint; (2) linearized alternating direction method of multiplier to efficiently handle the nonconvex minimum-monitor-unit constraint and nonlinear EUD objective.ResultsEUD optimization reduced the EUD and increased survival fraction. For example, for a head-and-neck patient, EUD optimization decreased the brainstem EUD from 5.52% to 3.86% for DO, and from 5.78% to 4.82% for JDPO, and increased the brainstem survival fraction from 72.9% to 81.6% for DO, and from 71.5% to 76.6% for JDPO. Furthermore, EUD optimization preserved PVDR from DO or JDPO.ConclusionsA novel EUD optimization method is proposed for SFRT that can reduce the EUD and increase the survival fraction.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.